Polymarket Science Milestones Traderv0.0.3

Exploits the predictable Nobel Prize announcement schedule in October, where Polymarket prices lag 15-30 minutes after official announcements. The skill uses Clarivate Citation Laureates data from September to identify likely winners, enabling rapid trades based on citation impact rather than retail hype.

Targets markets on overhyped claims like room-temperature superconductors or commercial fusion, applying dampening multipliers (e.g., 0.55x for superconductors) due to historical replication failures. This corrects for retail overpricing driven by media excitement, focusing on physics and materials science sectors.

Leverages clinicaltrials.gov data and regulatory timelines for markets on drug approvals (e.g., Alzheimer's treatments, CRISPR therapies). The skill applies positive multipliers (e.g., 1.15x for gene therapy) to exploit retail underestimation of established clinical pathways, particularly in biotechnology.

Analyzes markets on quantum computing achievements, applying a 0.85x multiplier to account for corporate marketing contamination versus published roadmaps. This helps traders navigate overoptimistic claims in tech sectors, focusing on realistic timelines based on engineering constraints.

Addresses markets predicting artificial general intelligence or AI consciousness by specific dates, using a 0.70x multiplier due to lack of agreed definitions and historical inaccuracies. This corrects for speculative retail behavior in the AI and software industries.

Offers a subscription-based service where users access the skill's signals to exploit mispricings in science markets. Revenue is generated through monthly fees or performance-based commissions on profitable trades, targeting retail and institutional traders.

Sells detailed reports and insights derived from the skill's analysis, such as Clarivate Citation Laureates predictions or hype cycle corrections. Clients include hedge funds, research firms, and academic institutions seeking edge in science investment.

Licenses the skill's technology to other trading platforms or financial institutions for integration into their systems. This provides automated trading capabilities for science markets, with revenue from licensing fees and customization services.